Upper extremity deep venous thrombosis

Vascular Medicine

Volumn 16, Issue 3, 2011, Pages 191-202

  Czihal, Michael ^a   Hoffmann, Ulrich ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

cancer; central venous catheter; Paget von Schroetter syndrome; thoracic outlet syndrome; upper extremity deep venous thrombosis

Indexed keywords

ALTEPLASE; ANTIVITAMIN K; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANGIOPLASTY; ARTICLE; BLOOD CLOT LYSIS; CENTRAL VENOUS CATHETER; CLINICAL FEATURE; COMORBIDITY; COMPRESSION THERAPY; DECOMPRESSION SURGERY; DISEASE COURSE; DISEASE SEVERITY; HUMAN; IMAGING SYSTEM; LUNG EMBOLISM; NON INVASIVE PROCEDURE; PATHOGENESIS; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; UPPER EXTREMITY DEEP VEIN THROMBOSIS;

ANTICOAGULANTS; COMPRESSION BANDAGES; DIAGNOSTIC IMAGING; ENDOVASCULAR PROCEDURES; HUMANS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; UPPER EXTREMITY DEEP VEIN THROMBOSIS; VASCULAR SURGICAL PROCEDURES;

EID: 79959250283     PISSN: 1358863X     EISSN: 14770377     Source Type: Journal    
DOI: 10.1177/1358863X10395657     Document Type: Article

References (88)

1. Joffe HV, Kucher N., Tapson VF, Goldhaber SZ Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation 2004 ; 110: 1605-1611. (Pubitemid 39297983)
2. Bernardi E., Pesavento R., Prandoni P. Upper extremity deep venous thrombosis. Semin Thromb Hemost 2006 ; 32: 729-736. (Pubitemid 44623381)
3. Prandoni P., Polistena P., Bernardi E., et al. Upper-extremity deep vein thrombosis. Risk factors, diagnosis, and complications. Arch Intern Med 1997 ; 157: 57-62. (Pubitemid 27027075)
4. Lechner D., Wiener C., Weltermann A., Eischer L., Eichinger S., Kyrle PA Comparison between idiopathic deep vein thrombosis of the upper and lower extremity regarding risk factors and recurrence. J Thromb Haemost 2008 ; 6: 1269-1274. (Pubitemid 352016305)
5. Persson LM, Arnhjort T., Larfars G., Rosfors S. Hemodynamic and morphologic evaluation of sequelae of primary upper extremity deep venous thromboses treated with anticoagulation. J Vasc Surg 2006 ; 43: 1230-1235. (Pubitemid 43825691)
6. Ascher E., Salles-Cunha S., Hingorani A. Morbidity and mortality associated with internal jugular vein thromboses. Vasc Endovasc Surg 2005 ; 39: 335-339. (Pubitemid 41061700)
7. Heron E., Lozinguez O., Emmerich J., Laurian C., Fiessinger JN Long-term sequelae of spontaneous axillary-subclavian venous thrombosis. Ann Intern Med 1999 ; 131: 510-513. (Pubitemid 29482395)
8. Joffe HV, Goldhaber SZ Upper-extremity deep vein thrombosis. Circulation 2002 ; 106: 1874-1880.
9. Shivakumar SP, Anderson DR, Couban S. Catheter-associated thrombosis in patients with malignancy. J Clin Oncol 2009 ; 27: 4858-4864.
10. Munoz FJ, Mismetti P., Poggio R., et al. Clinical outcome of patients with upper-extremity deep vein thrombosis: results from the RIETE Registry. Chest 2008 ; 133: 143-148.
11. Monreal M., Lafoz E., Ruiz J., Valls R., Alastrue A. Upper-extremity deep venous thrombosis and pulmonary embolism. A prospective study. Chest 1991 ; 99: 280-283.
12. Kooij JD, van der Zant FM, van Beek EJ, Reekers JA Pulmonary embolism in deep venous thrombosis of the upper extremity: more often in catheter-related thrombosis. Neth J Med 1997 ; 50: 238-242. (Pubitemid 27286645)
13. Flinterman LE, Van Der Meer FJ, Rosendaal FR, Doggen CJ Current perspective of venous thrombosis in the upper extremity. J Thromb Haemost 2008 ; 6: 1262-1266. (Pubitemid 352016303)
14. Van Stralen KJ, Blom JW, Doggen CJ, Rosendaal FR Strenuous sport activities involving the upper extremities increase the risk of venous thrombosis of the arm. J Thromb Haemost 2005 ; 3: 2110-2111. (Pubitemid 43086075)
15. Illig KA, Doyle AJ Paget-Schroetter syndrome: a comprehensive review. J Vasc Surg 2010 ; 51: 1538-1547.
16. Sanders RJ, Hammond SL Venous thoracic outlet syndrome. Hand Clin 2004 ; 20: 113-118, viii. (Pubitemid 38183050)
17. Vanti C., Natalini L., Romeo A., Tosarelli D., Pillastrini P. Conservative treatment of thoracic outlet syndrome. A review of the literature. Eura Medicophys 2007 ; 43: 55-70.
18. Gloviczki P., Kazmier FJ, Hollier LH Axillary-subclavian venous occlusion: the morbidity of a nonlethal disease. J Vasc Surg 1986 ; 4: 333-337. (Pubitemid 17177672)
19. Thompson RW, Schneider PA, Nelken NA, Skioldebrand CG, Stoney RJ Circumferential venolysis and paraclavicular thoracic outlet decompression for 'effort thrombosis' of the subclavian vein. J Vasc Surg 1992 ; 16: 723-732.
20. Sanders RJ, Rao NM Pectoralis minor obstruction of the axillary vein: report of six patients. J Vasc Surg 2007 ; 45: 1206-1211. (Pubitemid 46817826)
21. Jamieson CW Venous complications of the thoracic outlet syndrome. Eur J Vasc Surg 1987 ; 1: 1-3.
22. Girolami A., Prandoni P., Zanon E., Bagatella P., Girolami B. Venous thromboses of upper limbs are more frequently associated with occult cancer as compared with those of lower limbs. Blood Coagul Fibrinolysis 1999 ; 10: 455-457. (Pubitemid 30013709)
23. Linnemann B., Meister F., Schwonberg J., Schindewolf M., Zgouras D., Lindhoff-Last E. Hereditary and acquired thrombophilia in patients with upper extremity deep-vein thrombosis. Results from the MAISTHRO registry. Thromb Haemost 2008 ; 100: 440-446.
24. Heron E., Lozinguez O., Alhenc-Gelas M., Emmerich J., Fiessinger JN Hypercoagulable states in primary upper-extremity deep vein thrombosis. Arch Intern Med 2000 ; 160: 382-386. (Pubitemid 30075221)
25. Blom JW, Doggen CJ, Osanto S., Rosendaal FR Old and new risk factors for upper extremity deep venous thrombosis. J Thromb Haemost 2005 ; 3: 2471-2478. (Pubitemid 41727164)
26. Martinelli I., Battaglioli T., Bucciarelli P., Passamonti SM, Mannucci PM Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities. Circulation 2004 ; 110: 566-570. (Pubitemid 39031174)
27. Bombeli T., Basic A., Fehr J. Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems. Am J Hematol 2002 ; 70: 126-132.
28. Vaya A., Mira Y., Mateo J., et al. Prothrombin G20210A mutation and oral contraceptive use increase upper-extremity deep vein thrombotic risk. Thromb Haemost 2003 ; 89: 452-457. (Pubitemid 36329234)
29. Flinterman LE, van Hylckama Vlieg A., Rosendaal FR, Doggen CJ Venous thrombosis of the upper extremity: effect of blood group and coagulation factor levels on risk. Br J Haematol 2010 ; 149: 118-123.
30. Vaya A., Martinez TM, Romagnoli M., Lopez M., Ricart A., Corella D. Lack of association between hemorheological alterations and upper-extremity deep vein thrombosis. Clin Hemorheol Microcirc 2009 ; 41: 279-285.
31. Hingorani A., Ascher E., Markevich N., et al. Risk factors for mortality in patients with upper extremity and internal jugular deep venous thrombosis. J Vasc Surg 2005 ; 41: 476-478. (Pubitemid 40523592)
32. Verso M., Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol 2003 ; 21: 3665-3675. (Pubitemid 46594061)
33. Verso M., Agnelli G., Kamphuisen PW, et al. Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients. Intern Emerg Med 2008 ; 3: 117-122.
34. Van Rooden CJ, Rosendaal FR, Barge RM, et al. Central venous catheter related thrombosis in haematology patients and prediction of risk by screening with Doppler-ultrasound. Br J Haematol 2003 ; 123: 507-512. (Pubitemid 37363496)
35. Van Rooden CJ, Molhoek SG, Rosendaal FR, Schalij MJ, Meinders AE, Huisman MV Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads. J Cardiovasc Electrophysiol 2004 ; 15: 1258-1262. (Pubitemid 39612630)
36. Van Rooden CJ, Rosendaal FR, Meinders AE, Van Oostayen JA, Van Der Meer FJ, Huisman MV The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis. Haematologica 2004 ; 89: 201-206. (Pubitemid 38796495)
37. Van Rooden CJ, Schippers EF, Barge RM, et al. Infectious complications of central venous catheters increase the risk of catheter-related thrombosis in hematology patients: a prospective study. J Clin Oncol 2005 ; 23: 2655-2660. (Pubitemid 46179454)
38. Raad II, Luna M., Khalil SA, Costerton JW, Lam C., Bodey GP The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 1994 ; 271: 1014-1016. (Pubitemid 24099923)
39. Lee AY, Levine MN, Butler G., et al. Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol 2006 ; 24: 1404-1408. (Pubitemid 46622005)
40. Luciani A., Clement O., Halimi P., et al. Catheter-related upper extremity deep venous thrombosis in cancer patients: a prospective study based on Doppler US. Radiology 2001 ; 220: 655-660. (Pubitemid 32799971)
41. Tesselaar ME, Ouwerkerk J., Nooy MA, Rosendaal FR, Osanto S. Risk factors for catheter-related thrombosis in cancer patients. Eur J Cancer 2004 ; 40: 2253-2259. (Pubitemid 39348875)
42. Flinterman LE, van Hylckama Vlieg A., Rosendaal FR, Doggen CJ Recurrent thrombosis and survival after a first venous thrombosis of the upper extremity. Circulation 2008 ; 118: 1366-1372.
43. Rodrigues CA, Ferrarotto R., Filho RK, Novis YA, Hoff PM Venous thromboembolism and cancer: a systematic review. J Thromb Thrombolysis 2010 ; 30: 67-78.
44. Zangari M., Fink LM, Elice F., Zhan F., Adcock DM, Tricot GJ Thrombotic events in patients with cancer receiving antiangiogenesis agents. J Clin Oncol 2009 ; 27: 4865-4873.
45. Bennett CL, Silver SM, Djulbegovic B., et al. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA 2008 ; 299: 914-924. (Pubitemid 351397066)
46. Vaya A., Mira Y., Ferrando F., Corella D., Aznar J. Does obesity constitute a risk factor for upper-extremity deep vein thrombosis? Thromb Haemost 2005 ; 94: 228-230. (Pubitemid 40974734)
47. Chan WS, Ginsberg JS A review of upper extremity deep vein thrombosis in pregnancy: unmasking the 'ART' behind the clot. J Thromb Haemost 2006 ; 4: 1673-1677. (Pubitemid 44144791)
48. Bauersachs RM, Manolopoulos K., Hoppe I., Arin MJ, Schleussner E. More on: the 'ART' behind the clot: solving the mystery. J Thromb Haemost 2007 ; 5: 438-439. (Pubitemid 46139481)
49. Lindblad B., Tengborn L., Bergqvist D. Deep vein thrombosis of the axillary-subclavian veins: epidemiologic data, effects of different types of treatment and late sequelae. Eur J Vasc Surg 1988 ; 2: 161-165. (Pubitemid 19219063)
50. Rooden CJ, Tesselaar ME, Osanto S., Rosendaal FR, Huisman MV Deep vein thrombosis associated with central venous catheters - a review. J Thromb Haemost 2005 ; 3: 2409-2419. (Pubitemid 41727156)
51. Demondion X., Herbinet P., Van Sint JS, Boutry N., Chantelot C., Cotten A. Imaging assessment of thoracic outlet syndrome. Radiographics 2006 ; 26: 1735-1750.
52. Kahn SR, Elman EA, Bornais C., Blostein M., Wells PS Post-thrombotic syndrome, functional disability and quality of life after upper extremity deep venous thrombosis in adults. Thromb Haemost 2005 ; 93: 499-502. (Pubitemid 40392539)
53. Elman EE, Kahn SR The post-thrombotic syndrome after upper extremity deep venous thrombosis in adults: a systematic review. Thromb Res 2006 ; 117: 609-614.
54. Sabeti S., Schillinger M., Mlekusch W., Haumer M., Ahmadi R., Minar E. Treatment of subclavian-axillary vein thrombosis: long-term outcome of anticoagulation versus systemic thrombolysis. Thromb Res 2002 ; 108: 279-285. (Pubitemid 37025617)
55. Prandoni P., Bernardi E., Marchiori A., et al. The long term clinical course of acute deep vein thrombosis of the arm: prospective cohort study. BMJ 2004 ; 329: 484-485. (Pubitemid 39158892)
56. Jones MA, Lee DY, Segall JA, et al. Characterizing resolution of catheter-associated upper extremity deep venous thrombosis. J Vasc Surg 2010 ; 51: 108-113.
57. Monreal M., Raventos A., Lerma R., et al. Pulmonary embolism in patients with upper extremity DVT associated to venous central lines-a prospective study. Thromb Haemost 1994 ; 72: 548-550. (Pubitemid 24305648)
58. Baarslag HJ, Koopman MM, Hutten BA, et al. Long-term follow-up of patients with suspected deep vein thrombosis of the upper extremity: survival, risk factors and post-thrombotic syndrome. Eur J Intern Med 2004 ; 15: 503-507. (Pubitemid 40164479)
59. Constans J., Salmi LR, Sevestre-Pietri MA, et al. A clinical prediction score for upper extremity deep venous thrombosis. Thromb Haemost 2008 ; 99: 202-207.
60. Di Nisio M., van Sluis GL, Bossuyt PM, Buller HR, Porreca E., Rutjes AW Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review. J Thromb Haemost 2010 ; 8: 684-692.
61. Merminod T., Pellicciotta S., Bounameaux H. Limited usefulness of D-dimer in suspected deep vein thrombosis of the upper extremities. Blood Coagul Fibrinolysis 2006 ; 17: 225-226.
62. Chin EE, Zimmerman PT, Grant EG Sonographic evaluation of upper extremity deep venous thrombosis. J Ultrasound Med 2005 ; 24: 829-838.
63. Patel MC, Berman LH, Moss HA, McPherson SJ Subclavian and internal jugular veins at Doppler US: abnormal cardiac pulsatility and respiratory phasicity as a predictor of complete central occlusion. Radiology 1999 ; 211: 579-583. (Pubitemid 29206834)
64. Baarslag HJ, van Beek EJ, Koopman MM, Reekers JA Prospective study of color duplex ultrasonography compared with contrast venography in patients suspected of having deep venous thrombosis of the upper extremities. Ann Intern Med 2002 ; 136: 865-872. (Pubitemid 34625698)
65. Mustafa BO, Rathbun SW, Whitsett TL, Raskob GE Sensitivity and specificity of ultrasonography in the diagnosis of upper extremity deep vein thrombosis: a systematic review. Arch Intern Med 2002 ; 162: 401-404. (Pubitemid 34150640)
66. Hartnell GG, Hughes LA, Finn JP, Longmaid HE III. Magnetic resonance angiography of the central chest veins. A new gold standard? Chest 1995 ; 107: 1053-1057.
67. Kroencke TJ, Taupitz M., Arnold R., Fritsche L., Hamm B. Three-dimensional gadolinium-enhanced magnetic resonance venography in suspected thrombo-occlusive disease of the central chest veins. Chest 2001 ; 120: 1570-1576. (Pubitemid 33078474)
68. Baarslag HJ, van Beek EJ, Reekers JA Magnetic resonance venography in consecutive patients with suspected deep vein thrombosis of the upper extremity: initial experience. Acta Radiol 2004 ; 45: 38-43.
69. Spiezia L., Simioni P. Upper extremity deep vein thrombosis. Intern Emerg Med 2010 ; 5: 103-109.
70. Hoffmann U., Spannagl M. Deep venous thrombosis of the upper extremity: is thrombophilia a relevant clinical issue? Thromb Haemost 2008 ; 100: 369-370.
71. Khamashta MA, Cuadrado MJ, Mujic F., Taub NA, Hunt BJ, Hughes GR The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995 ; 332: 993-997.
72. Rosove MH, Brewer PM Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992 ; 117: 303-308.
73. Carrier M., Le Gal G., Wells PS, Fergusson D., Ramsay T., Rodger MA Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism? Ann Intern Med 2008 ; 149: 323-333.
74. Savage KJ, Wells PS, Schulz V., et al. Outpatient use of low molecular weight heparin (Dalteparin) for the treatment of deep vein thrombosis of the upper extremity. Thromb Haemost 1999 ; 82: 1008-1010. (Pubitemid 29419709)
75. Kovacs MJ, Kahn SR, Rodger M., et al. A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study). J Thromb Haemost 2007 ; 5: 1650-1653. (Pubitemid 47091406)
76. Kearon C., Kahn SR, Agnelli G., Goldhaber S., Raskob GE, Comerota AJ ; American College of Chest Physicians. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8 th Edition). Chest 2008 ; 133 (6 suppl). 454S - 545S. (Pubitemid 351892971)
77. Lee AY Anti-thrombotic therapy in cancer patients. Expert Opin Pharmacother 2003 ; 4: 2213-2220. (Pubitemid 37541235)
78. Louzada ML, Majeed H., Wells PS Efficacy of low-molecular-weight-heparin versus vitamin K antagonists for long term treatment of cancer-associated venous thromboembolism in adults: a systematic review of randomized controlled trials. Thromb Res 2009 ; 123: 837-844.
79. Thomas IH, Zierler BK An integrative review of outcomes in patients with acute primary upper extremity deep venous thrombosis following no treatment or treatment with anticoagulation, thrombolysis, or surgical algorithms. Vasc Endovascular Surg 2005 ; 39: 163-174. (Pubitemid 40489852)
80. Ponec D., Irwin D., Haire WD, Hill PA, Li X., McCluskey ER Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial-the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial. J Vasc Interv Radiol 2001 ; 12: 951-955. (Pubitemid 32756865)
81. Couban S., Goodyear M., Burnell M., et al. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol 2005 ; 23: 4063-4069. (Pubitemid 46211311)
82. Young AM, Billingham LJ, Begum G., et al. Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial. Lancet 2009 ; 373: 567-574.
83. Verso M., Agnelli G., Bertoglio S., et al. Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients. J Clin Oncol 2005 ; 23: 4057-4062. (Pubitemid 46211310)
84. Karthaus M., Kretzschmar A., Kroning H., et al. Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial. Ann Oncol 2006 ; 17: 289-296. (Pubitemid 43160120)
85. Akl EA, Kamath G., Yosuico V., et al. Thromboprophylaxis for patients with cancer and central venous catheters: a systematic review and a meta-analysis. Cancer 2008 ; 112: 2483-2492.
86. Carrier M., Tay J., Fergusson D., Wells PS Thromboprophylaxis for catheter-related thrombosis in patients with cancer: a systematic review of the randomized, controlled trials. J Thromb Haemost 2007 ; 5: 2552-2554. (Pubitemid 350154369)
87. Chaukiyal P., Nautiyal A., Radhakrishnan S., Singh S., Navaneethan SD Thromboprophylaxis in cancer patients with central venous catheters. A systematic review and meta-analysis. Thromb Haemost 2008 ; 99: 38-43.
88. Geerts WH, Bergqvist D., Pineo GF, et al.; American College of Chest Physicians. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8 th Edition). Chest 2008 ; 133 (6 suppl). 381S - 453S. (Pubitemid 351894916)